Phase Ii Study Of Pembrolizumab (Pembro) Plus Platinum Doublet Chemotherapy And Radiotherapy As First-Line Therapy For Unresectable, Locally Advanced Stage Iii Nsclc: Keynote-799.

Salma K. Jabbour,Ki Hyeong Lee,Nicolaj Frost,Dariusz Kowalski, Valeriy Vladimirovich Breder,Theodore Pollock,Noemi Reguart,Baerin Houghton,Xavier Quantin,Steven M. Keller,Hong Liu,Bilal Piperdi,Martin Reck

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 17|浏览34

暂无评分

摘要

9008Background: KEYNOTE-799 (NCT03631784) evaluates pembro plus concurrent chemoradiation therapy (CCRT) in pts with unresectable, locally advanced stage III NSCLC. Methods: In this phase 2, nonran...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要